tiprankstipranks
Bicycle Therapeutics Ltd (BCYC)
NASDAQ:BCYC
US Market

Bicycle Therapeutics (BCYC) Financial Statements

Compare
371 Followers

Bicycle Therapeutics Financial Overview

Bicycle Therapeutics's market cap is currently $757.60M. The company's EPS TTM is $-2.878; its P/E ratio is ―; Bicycle Therapeutics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.85. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 26.98M$ 14.46M$ 11.70M$ 10.39M$ 13.80M
Gross Profit$ 20.51M$ 10.78M$ -33.18M$ -22.76M$ -11.74M
Operating Income$ -189.95M$ -116.65M$ -65.62M$ -51.96M$ -26.30M
EBITDA$ -183.40M$ -112.96M$ -64.08M$ -50.39M$ -30.03M
Net Income$ -180.66M$ -112.72M$ -66.82M$ -51.01M$ -30.61M
Balance Sheet
Cash & Short-Term Investments$ 526.42M$ 339.15M$ 438.68M$ 135.99M$ 92.12M
Total Assets$ 595.34M$ 410.61M$ 479.79M$ 161.15M$ 110.19M
Total Debt$ 44.96M$ 44.33M$ 44.34M$ 15.78M$ 1.89M
Net Debt$ -481.47M$ -294.83M$ -394.34M$ -120.22M$ -90.23M
Total Liabilities$ 224.41M$ 139.83M$ 133.54M$ 65.69M$ 17.00M
Stockholders' Equity$ 370.93M$ 270.78M$ 346.25M$ 95.46M$ 93.20M
Cash Flow
Free Cash Flow$ -63.56M$ -105.10M$ -16.82M$ -18.99M$ -30.17M
Operating Cash Flow$ -60.63M$ -86.11M$ -14.79M$ -17.79M$ -28.61M
Investing Cash Flow$ -2.93M$ -18.99M$ -2.03M$ -1.20M$ -1.55M
Financing Cash Flow$ 250.03M$ 6.69M$ 320.73M$ 62.84M$ 58.44M
Currency in USD

Bicycle Therapeutics Earnings and Revenue History

Bicycle Therapeutics Debt to Assets

Bicycle Therapeutics Cash Flow

Bicycle Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis